# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4413881 | B | Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 60 | ALA4411322 | protein complex format | Scientific Literature | |
2. | ALA4413882 | B | Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 60 | ALA4411322 | protein complex format | Scientific Literature | |
3. | ALA4413883 | B | Selectivity ratio of IC50 for human integrin alphavbeta6 receptor to IC50 for human integrin alphavbeta8 receptor | Homo sapiens | 39 | ALA4411322 | assay format | Scientific Literature | |
4. | ALA4413884 | B | Inhibition of human vitronectin binding to human integrin alphavbeta3 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 6 | ALA4411322 | protein complex format | Scientific Literature | |
5. | ALA4413885 | B | Inhibition of human vitronectin binding to human integrin alphavbeta5 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 6 | ALA4411322 | protein complex format | Scientific Literature | |
6. | ALA4413886 | B | Inhibition of human fibronectin binding to human integrin alpha5beta1 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 6 | ALA4411322 | protein complex format | Scientific Literature | |
7. | ALA4413887 | B | Inhibition of human fibrinogen binding to human platelet integrin alpha2b-beta3 receptor after 1 hr by solid-phase binding assay | Homo sapiens | 6 | ALA4411322 | assay format | Scientific Literature | |
8. | ALA4413890 | A | Stability in 90% human serum assessed as drug degradation at 1 mM after 180 mins by HPLC analysis | Homo sapiens | 1 | ALA4411322 | cell-free format | Scientific Literature |